Most Read Articles
04 Sep 2015
Seborrheic dermatitis may have a negative influence on a patient's quality of life according to a cross-sectional study conducted in Thailand.
01 Jun 2013

An article by the same team in Leeds (see above) addresses the question of swabs for the diagnosis of gonorrhoea in the cohort of 3,973 women.

Stephen Padilla, Yesterday
Lebrikizumab, an interleukin (IL)-13 monoclonal antibody, taken every 4 weeks and in combination with topical corticosteroid (TCS) is safe and effective in patients with moderate-to-severe atopic dermatitis (AD), results from a phase II study have shown.
20 Jan 2016
Topical pine tar exhibits efficacy with minimal safety concerns in the treatment of a range of skin conditions, as assessed in a review.

Management of atopic dermatitis with topical calcineurin inhibitor

04 Dec 2017
At the 42nd Annual Dermatology Conference 2017 held recently in Kuala Lumpur, Professor Michael J. Cork spoke on the interaction between genetic and environmental factors as a primary event in the development of atopic dermatitis (AD) and highlighted the role of topical calcineurin inhibitors (TCIs) in the management of AD.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
04 Sep 2015
Seborrheic dermatitis may have a negative influence on a patient's quality of life according to a cross-sectional study conducted in Thailand.
01 Jun 2013

An article by the same team in Leeds (see above) addresses the question of swabs for the diagnosis of gonorrhoea in the cohort of 3,973 women.

Stephen Padilla, Yesterday
Lebrikizumab, an interleukin (IL)-13 monoclonal antibody, taken every 4 weeks and in combination with topical corticosteroid (TCS) is safe and effective in patients with moderate-to-severe atopic dermatitis (AD), results from a phase II study have shown.
20 Jan 2016
Topical pine tar exhibits efficacy with minimal safety concerns in the treatment of a range of skin conditions, as assessed in a review.